Iobitridol

DB12407ApprovedWithdrawnSmall molecule

Iobitridol is an iodine-based contrast agent used with X-ray or CT imaging. Iobitridol has been used in trials studying the diagnostic of Diagnostic Imaging, Coronary Artery Disease, Type 2 Diabetes Mellitus, and Coronary Atherosclerosis.

Formula / weight: C₂₀H₂₈I₃N₃O₉ · 835.169 g/mol (avg)

Resolves to

Compound

UNII182ECH14UHCAS136949-58-1ChEMBLCHEMBL2107212ChEBI31701PubChem65985KEGGD01181

Clinical / RWD

RxNorm87639ATCV08AB11

Structure

InChIKeyYLPBXIKWXNRACS-UHFFFAOYSA-NSMILESCN(CC(O)CO)C(=O)C1=C(I)C(C(=O)N(C)CC(O)CO)=C(I)C(NC(=O)C(CO)CO)=C1I

What you can answer from here — as of March 06, 2025

5Clinical trialsPhase, status and sponsor resolved per trial

9Structured indicationsCondition, population, route and combination as fields, not prose

4ContraindicationsEach with its own population and attribute set

54Marketed productsAcross 5 countries and 5 labellers

1ATC codeIncluding every combination product, plus 10 drug categories

1+ReferenceStructured and connected to the statements they support

Which other approved drugs treat the same conditions as Iobitridol, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account